Skip to content
VisionGate Logo
  • Home
  • About
    • Our Team
  • Our Technology
    • Non-Intrusive Testing
    • Patented Cell-CT Imaging
    • AI Powered Detection
  • News
  • Patents
  • Publications
  • Contact

Blog

  • NewsFPO
  • Patents
  • PublicationsFPO
  • October 17, 2026

    WCLC 2026  – A recent presentation at the 2026 World Conference on Lung Cancer shows that LuCED can detect Stage 1 lung cancer with 94% sensitivity

    More Information

    News

  • October 6, 2026

    WCLC 2026 – LuCED Assay For Detection Of Early-Stage Lung Cancer From Home-Collected Sputum

    More Information

    Publications

  • October 6, 2026

    VisionGateAI Awarded Prestigious Andy Hill CARE Fund Grant to Advance Early-Stage Lung Cancer Detection

    More Information

    News

  • May 8, 2026

    #12,602,781:
    AI-BASED CELL CLASSIFICATION METHOD AND SYSTEM

    More Information

    Patents

  • January 26, 2026

    AI Discrimination of Adenocarcinoma vs. Squamous Carcinoma in Detecting NSCLC Non-Invasively from Sputum Using Cell-CT Single-Cell Analysis in 3D

    More Information

    Publications

  • October 24, 2025

    WCLC 2025 – AI subclassification of abnormal cells into pre-cancerous and malignant categories based on 3D cell imaging

    More Information

    News

  • June 13, 2025

    VisionGate Launches Clinical Study at Northwestern Medicine, Using the Breakthrough AI-powered Cell-CT for Detection of Early-Stage Lung Cancer in the Battle Against the World’s #1 Cancer Killer

    More Information

    News

  • November 12, 2024

    VisionGate Has Revised and Updated Its Website

    More Information

    News

  • August 26, 2024

    Patents from NeoPath, a predecessor to VisionGate are being highlighted at an exhibit at the Seattle Museum of History and Industry (MOHAI)

    More Information

    News

  • June 25, 2024

    #12,019,008:
    MORPHOMETRIC DETECTION OF MALIGNANCY ASSOCIATED CHANGE

    More Information

    Patents

12Next

Follow Us

x icon
  • Home
  • About
  • Our Technology
Contact

© Copyright 2005 – 2026 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

3 Questions to Assess Your Risk

 Early detection of lung cancer is important to keeping you healthy and living your life to the fullest.

Has a family member had Lung Cancer? *
Have you smoked or been exposed to secondhand smoke? *

If you are over the age of 60 or answer "Yes" to any of the questions above, you may be at an increased risk.

This test is not a diagnosis but can help you recognize factors that may increase your risk of developing lung cancer. Next, You can subscribe to learn more from VisionGate. Then, you'll be redirected to a page of resources that can aid you in discussions with your doctor, or click here to access the page directly.

If you are above the age of 50 and answered "Yes" to any of the questions, you may be at an increased risk of developing lung cancer, but this is not a diagnosis. Use the link below to download resources that can help you talk to your doctor. Click Here to Download
We're sorry! There was an error submitting the test. Please try again later.

*No personal information is collected or saved through this form without your consent. Only your email and name will be saved if you opt-in.

visiongate logo
Contact
  • Home
  • About
  • Our Technology

© Copyright 2005 – 2026 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

Page load link
Go to Top